Ayman Jamal, MD
Cardiovascular Disease · Phoenix, AZNPI 1083600845
Payments from drug & device makers
Across 311 payments — averaging $248.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardiovascular Systems Inc.$41K
- Medtronic$17K
- Abbott$8K
- Celonova Biosciences, Inc.$3K
- Edwards Lifesciences$2K
- Abiomed$1K
- plus $5K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardiovascular Systems Inc. | 34 | $41,069 |
| Medtronic(2 entities) | 39 | $17,295 |
| Abbott | 60 | $8,104 |
| Celonova Biosciences, Inc. | 3 | $2,633 |
| Edwards Lifesciences | 28 | $1,703 |
| Abiomed | 20 | $1,268 |
| Boston Scientific | 23 | $884 |
| Biosense Webster, Inc. | 15 | $579 |
| W. L. Gore & Associates, Inc. | 3 | $403 |
| Penumbra, Inc. | 3 | $382 |
| Bolton Medical Inc | 4 | $299 |
| Inspiremd Ltd | 3 | $241 |
| Cleerly, Inc. | 8 | $240 |
| Kaneka Medical America LLC | 1 | $199 |
| Atricure, Inc. | 4 | $197 |
| AstraZeneca | 5 | $189 |
| Endologix LLC | 2 | $188 |
| Novartis | 8 | $159 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $149 |
| Pfizer | 7 | $131 |
| Heartflow, Inc. | 1 | $121 |
| Angiodynamics, Inc. | 1 | $119 |
| Boehringer Ingelheim | 4 | $118 |
| Baxter Healthcare | 3 | $100 |
| Johnson & Johnson | 3 | $74 |
| Kestra Medical Technology Services, Inc. | 3 | $69 |
| Novo Nordisk | 3 | $68 |
| Surmodics, Inc. | 1 | $64 |
| Merck | 3 | $62 |
| Saranas, Inc. | 1 | $46 |
| Amgen | 2 | $32 |
| Cvrx, Inc. | 1 | $23 |
| ZOLL Respicardia, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $22 |
| GSK | 1 | $21 |
| Corcept Therapeutics | 1 | $20 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| Philips North America LLC | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Cook Medical LLC | 1 | $14 |
How this compares
$77,358 in reported general payments places this provider in the 90th percentile of 423 cardiovascular disease providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Phoenix
- Ashish GuptaPhoenix$1.2M
- Rajkumar SugumaranPhoenix$957K
- Robert ScottPhoenix$331K
- Julie RosenthalPhoenix$313K
- Tabitha MoePhoenix$256K
- Mehrdad SaririanPhoenix$158K
- Jesse SethiPhoenix$150K
- Adam SabbathPhoenix$109K
- Venkataramanan GangadharanPhoenix$97K
- Namit RohantPhoenix$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.